Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 20 of 58

1.

Development and external validation of a faecal immunochemical test-based prediction model for colorectal cancer detection in symptomatic patients.

Cubiella J, Vega P, Salve M, Díaz-Ondina M, Alves MT, Quintero E, Álvarez-Sánchez V, Fernández-Bañares F, Boadas J, Campo R, Bujanda L, Clofent J, Ferrandez Á, Torrealba L, Piñol V, Rodríguez-Alcalde D, Hernández V, Fernández-Seara J; COLONPREDICT study investigators..

BMC Med. 2016 Aug 31;14(1):128. doi: 10.1186/s12916-016-0668-5.

2.

SOX9-regulated cell plasticity in colorectal metastasis is attenuated by rapamycin.

Carrasco-Garcia E, Lopez L, Aldaz P, Arevalo S, Aldaregia J, Egaña L, Bujanda L, Cheung M, Sampron N, Garcia I, Matheu A.

Sci Rep. 2016 Aug 30;6:32350. doi: 10.1038/srep32350.

3.

The Fanconi anemia DNA damage repair pathway in the spotlight for germline predisposition to colorectal cancer.

Esteban-Jurado C, Franch-Expósito S, Muñoz J, Ocaña T, Carballal S, López-Cerón M, Cuatrecasas M, Vila-Casadesús M, Lozano JJ, Serra E, Beltran S, Brea-Fernández A, Ruiz-Ponte C, Castells A, Bujanda L, Garre P, Caldés T, Cubiella J, Balaguer F, Castellví-Bel S.

Eur J Hum Genet. 2016 Oct;24(10):1501-5. doi: 10.1038/ejhg.2016.44. Epub 2016 May 11.

4.

Non-invasive biomarkers in pancreatic cancer diagnosis: what we need versus what we have.

Herreros-Villanueva M, Bujanda L.

Ann Transl Med. 2016 Apr;4(7):134. doi: 10.21037/atm.2016.03.44. Review.

5.

Risk of Advanced Neoplasia in First-Degree Relatives with Colorectal Cancer: A Large Multicenter Cross-Sectional Study.

Quintero E, Carrillo M, Leoz ML, Cubiella J, Gargallo C, Lanas A, Bujanda L, Gimeno-García AZ, Hernández-Guerra M, Nicolás-Pérez D, Alonso-Abreu I, Morillas JD, Balaguer F, Muriel A; Oncology Group of the Asociación Española de Gastroenterología (AEG)..

PLoS Med. 2016 May 3;13(5):e1002008. doi: 10.1371/journal.pmed.1002008. eCollection 2016 May 3.

6.

Prevalence of severe esophagitis in Spain. Results of the PRESS study (Prevalence and Risk factors for Esophagitis in Spain: A cross-sectional study).

Piqué N, Ponce M, Garrigues V, Rodrigo L, Calvo F, de Argila CM, Borda F, Naranjo A, Alcedo J, José Soria M, Rey E, Bujanda L, Gisbert JP, Suarez D, Calvet X, Ponce J; PRESS Study Group..

United European Gastroenterol J. 2016 Apr;4(2):229-35. doi: 10.1177/2050640615595916. Epub 2015 Jul 24.

7.

Genetic Variants Associated with Colorectal Adenoma Susceptibility.

Abulí A, Castells A, Bujanda L, Lozano JJ, Bessa X, Hernández C, Álvarez-Urturi C, Pellisé M, Esteban-Jurado C, Hijona E, Burón A, Macià F, Grau J, Guayta R, Castellví-Bel S, Andreu M; PROCOLON research group..

PLoS One. 2016 Apr 14;11(4):e0153084. doi: 10.1371/journal.pone.0153084. eCollection 2016 Apr 14.

8.

Glypican-1 in exosomes as biomarker for early detection of pancreatic cancer.

Herreros-Villanueva M, Bujanda L.

Ann Transl Med. 2016 Feb;4(4):64. doi: 10.3978/j.issn.2305-5839.2015.10.39.

9.

Effect of pravastatin on the survival of patients with advanced gastric cancer.

Bujanda L, Rodríguez-González A, Sarasqueta C, Eizaguirre E, Hijona E, Marín JJ, Perugorria MJ, Banales JM, Cosme A.

Oncotarget. 2016 Jan 26;7(4):4379-84. doi: 10.18632/oncotarget.6777.

10.

Ursodeoxycholic acid inhibits hepatic cystogenesis in experimental models of polycystic liver disease.

Munoz-Garrido P, Marin JJ, Perugorria MJ, Urribarri AD, Erice O, Sáez E, Úriz M, Sarvide S, Portu A, Concepcion AR, Romero MR, Monte MJ, Santos-Laso Á, Hijona E, Jimenez-Agüero R, Marzioni M, Beuers U, Masyuk TV, LaRusso NF, Prieto J, Bujanda L, Drenth JP, Banales JM.

J Hepatol. 2015 Oct;63(4):952-61. doi: 10.1016/j.jhep.2015.05.023. Epub 2015 Jun 1.

11.

Genome-wide analysis of the human p53 transcriptional network unveils a lncRNA tumour suppressor signature.

Sánchez Y, Segura V, Marín-Béjar O, Athie A, Marchese FP, González J, Bujanda L, Guo S, Matheu A, Huarte M.

Nat Commun. 2014 Dec 19;5:5812. doi: 10.1038/ncomms6812.

12.

Diagnostic accuracy of fecal immunochemical test in average- and familial-risk colorectal cancer screening.

Cubiella J, Castro I, Hernandez V, González-Mao C, Rivera C, Iglesias F, Alves MT, Cid L, Soto S, De-Castro L, Vega P, Hermo JA, Macenlle R, Martínez A, Estevez P, Cid E, Herreros-Villanueva M, Portillo I, Bujanda L, Fernández-Seara J; COLONPREV study investigators..

United European Gastroenterol J. 2014 Dec;2(6):522-9. doi: 10.1177/2050640614553285.

13.

Polycystic liver diseases: advanced insights into the molecular mechanisms.

Perugorria MJ, Masyuk TV, Marin JJ, Marzioni M, Bujanda L, LaRusso NF, Banales JM.

Nat Rev Gastroenterol Hepatol. 2014 Dec;11(12):750-61. doi: 10.1038/nrgastro.2014.155. Epub 2014 Sep 30. Review.

14.

Novel equation to determine the hepatic triglyceride concentration in humans by MRI: diagnosis and monitoring of NAFLD in obese patients before and after bariatric surgery.

Jiménez-Agüero R, Emparanza JI, Beguiristain A, Bujanda L, Alustiza JM, García E, Hijona E, Gallego L, Sánchez-González J, Perugorria MJ, Asensio JI, Larburu S, Garmendia M, Larzabal M, Portillo MP, Aguirre L, Banales JM.

BMC Med. 2014 Aug 26;12:137. doi: 10.1186/s12916-014-0137-y.

15.

Whole-exome sequencing identifies rare pathogenic variants in new predisposition genes for familial colorectal cancer.

Esteban-Jurado C, Vila-Casadesús M, Garre P, Lozano JJ, Pristoupilova A, Beltran S, Muñoz J, Ocaña T, Balaguer F, López-Cerón M, Cuatrecasas M, Franch-Expósito S, Piqué JM, Castells A, Carracedo A, Ruiz-Ponte C, Abulí A, Bessa X, Andreu M, Bujanda L, Caldés T, Castellví-Bel S.

Genet Med. 2015 Feb;17(2):131-42. doi: 10.1038/gim.2014.89. Epub 2014 Jul 24. Erratum in: Genet Med. 2014 Dec;16(12):988-9.

16.

Current approaches for predicting a lack of response to anti-EGFR therapy in KRAS wild-type patients.

Er TK, Chen CC, Bujanda L, Herreros-Villanueva M.

Biomed Res Int. 2014;2014:591867. doi: 10.1155/2014/591867. Epub 2014 Jun 18. Review.

17.

Effects of resveratrol and other polyphenols in hepatic steatosis.

Aguirre L, Portillo MP, Hijona E, Bujanda L.

World J Gastroenterol. 2014 Jun 21;20(23):7366-80. doi: 10.3748/wjg.v20.i23.7366. Review.

18.

The MLH1 c.1852_1853delinsGC (p.K618A) variant in colorectal cancer: genetic association study in 18,723 individuals.

Abulí A, Bujanda L, Muñoz J, Buch S, Schafmayer C, Valeria Maiorana M, Veneroni S, van Wezel T, Liu T, Westers H, Esteban-Jurado C, Ocaña T, Piqué JM, Andreu M, Jover R, Carracedo A, Xicola RM, Llor X, Castells A; EPICOLON Consortium., Dunlop M, Hofstra R, Lindblom A, Wijnen J, Peterlongo P, Hampe J, Ruiz-Ponte C, Castellví-Bel S.

PLoS One. 2014 Apr 17;9(4):e95022. doi: 10.1371/journal.pone.0095022. eCollection 2014 Apr 17.

19.

Differential activity of GSK-3 isoforms regulates NF-κB and TRAIL- or TNFα induced apoptosis in pancreatic cancer cells.

Zhang JS, Herreros-Villanueva M, Koenig A, Deng Z, de Narvajas AA, Gomez TS, Meng X, Bujanda L, Ellenrieder V, Li XK, Kaufmann SH, Billadeau DD.

Cell Death Dis. 2014 Mar 27;5:e1142. doi: 10.1038/cddis.2014.102. Erratum in: Cell Death Dis. 2014 Aug;5:e1365. Herreros-Vilanueva, M [corrected to Herreros-Villanueva, M].

20.

Embryonic stem cell factors and pancreatic cancer.

Herreros-Villanueva M, Bujanda L, Billadeau DD, Zhang JS.

World J Gastroenterol. 2014 Mar 7;20(9):2247-54. doi: 10.3748/wjg.v20.i9.2247. Review.

Supplemental Content

Loading ...
Support Center